Literature DB >> 3780986

A phase II study to evaluate tamoxifen in pancreatic adenocarcinoma.

M C Crowson, A Dorrell, E B Rolfe, J W Fielding.   

Abstract

Oestrogen receptors have been demonstrated in pancreatic adenocarcinoma and it has been suggested that tamoxifen increases patient survival. This study of 14 patients with unresectable carcinoma of the pancreas fails to demonstrate any objective response from endocrine manipulation using tamoxifen.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3780986

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  8 in total

Review 1.  Treatment of pancreatic cancer. Promises and problems of tamoxifen, somatostatin analogs, and gemcitabine.

Authors:  L Rosenberg
Journal:  Int J Pancreatol       Date:  1997-10

Review 2.  Pancreatic cancer in 1988. Possibilities and probabilities.

Authors:  A L Warshaw; R S Swanson
Journal:  Ann Surg       Date:  1988-11       Impact factor: 12.969

3.  Pancreatic cancer.

Authors:  J P Neoptolemos; G Blackledge; D Spooner
Journal:  Br Med J (Clin Res Ed)       Date:  1988-03-19

Review 4.  Influence of sex hormones on pancreatic cancer.

Authors:  A Andrén-Sandberg; J Johansson
Journal:  Int J Pancreatol       Date:  1990 Aug-Nov

5.  Effects of sex steroid hormones on pancreatic cancer in the rat.

Authors:  D S Longnecker; C Sumi
Journal:  Int J Pancreatol       Date:  1990 Aug-Nov

6.  A pilot study of estrogen receptor (ER) expression in pancreatic ductal adenocarcinoma (PDAC).

Authors:  Kai Siang Chan; Bernard Chi Shern Ho; Vishal G Shelat
Journal:  Transl Gastroenterol Hepatol       Date:  2021-01-05

7.  Oophorectomy has no effect on experimental pancreatic carcinogenesis in the Syrian hamster.

Authors:  J F Chester; R I Nicholson; J V Lever; A R Turnbull; D C Britton
Journal:  Br J Cancer       Date:  1989-05       Impact factor: 7.640

8.  Expression of estrogen receptor beta isoforms in pancreatic adenocarcinoma.

Authors:  Mamoun Younes; Charles J Ly; Kanchan Singh; Atilla Ertan; Pamela S Younes; Jennifer M Bailey
Journal:  Oncotarget       Date:  2018-12-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.